SK Bio-Pharmaceuticals Announces New CEO

SK Biopharmaceuticals has appointed a new CEO to lead the development and commercialization of its drug pipeline and to bring the South Korean based company into the global marketplace. As hinted at in this article, hidden among its portfolio is a drug discovery program to identify molecules that interact with TDP-43, a key protein in ALS.

Click here to read more.

Share this: